fda warning letters compounded semaglutide tirzepatide september 2025 to Restrict Ingredients Used in Mass-Marketed GLP-1s, Crack Down on Misleading Ads National Hispanic Medical Association |

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Her work highlights the importance of understanding how different factors can shape disease risk and outcomes

TRANSCEND-T2D-1: Retatrutide Phase 3 Diabetes Results (March 2026) First Phase 3 retatrutide trial in type 2 diabetes 16.8% weight loss and -2.0% A1C at 12 mg over 40 weeks

And, although no data currently exists, consideration should also be given to a potential impact on the absorption of oral hormone replacement therapy

Interpretation with a qualified provider supports informed decision-making